1. Insights into atherosclerosis using nanotechnology. Jayagopal A, Linton MF, Fazio S, Haselton FR (2010) Curr Atheroscler Rep 12(3): 209-15
    › Primary publication · 20425261 (PubMed) · PMC2863145 (PubMed Central)
  2. High-density lipoprotein therapeutics and cardiovascular prevention. Fazio S, Linton MF (2010) J Clin Lipidol 4(5): 411-9
    › Primary publication · 21122685 (PubMed)
  3. Combined vitamin C and vitamin E deficiency worsens early atherosclerosis in apolipoprotein E-deficient mice. Babaev VR, Li L, Shah S, Fazio S, Linton MF, May JM (2010) Arterioscler Thromb Vasc Biol 30(9): 1751-7
    › Primary publication · 20558818 (PubMed) · PMC2924448 (PubMed Central)
  4. 6-Mercaptopurine, monocytes, and atherosclerosis. Linton MF, Fazio S (2010) Arterioscler Thromb Vasc Biol 30(8): 1494-6
    › Primary publication · 20631345 (PubMed) · PMC2922006 (PubMed Central)
  5. Renal dysfunction potentiates foam cell formation by repressing ABCA1. Zuo Y, Yancey P, Castro I, Khan WN, Khan W, Motojima M, Ichikawa I, Fogo AB, Linton MF, Fazio S, Kon V (2009) Arterioscler Thromb Vasc Biol 29(9): 1277-82
    › Primary publication · 19667109 (PubMed) · PMC2748735 (PubMed Central)
  6. Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis. Erbay E, Babaev VR, Mayers JR, Makowski L, Charles KN, Snitow ME, Fazio S, Wiest MM, Watkins SM, Linton MF, Hotamisligil GS (2009) Nat Med 15(12): 1383-91
    › Primary publication · 19966778 (PubMed) · PMC2790330 (PubMed Central)
  7. Quantum dot mediated imaging of atherosclerosis. Jayagopal A, Su YR, Blakemore JL, Linton MF, Fazio S, Haselton FR (2009) Nanotechnology 20(16): 165102
    › Primary publication · 19420562 (PubMed) · PMC2718756 (PubMed Central)
  8. Prevalence and determinants of metabolic syndrome according to three definitions in middle-aged Chinese men. Villegas R, Xiang YB, Yang G, Cai Q, Fazio S, Linton MF, Elasy T, Xu WH, Li H, Cai H, Gao YT, Zheng W, Shu XO (2009) Metab Syndr Relat Disord 7(1): 37-45
    › Primary publication · 19032041 (PubMed) · PMC3135894 (PubMed Central)
  9. Fenofibrate and risk of minor amputations in diabetes. Fazio S, Linton MF (2009) Lancet 373(9677): 1740-1
    › Primary publication · 19465214 (PubMed)
  10. Elevated high-density lipoprotein (HDL) levels due to hepatic lipase mutations do not reduce cardiovascular disease risk: another strike against the HDL dogma. Fazio S, Linton MF (2009) J Clin Endocrinol Metab 94(4): 1081-3
    › Primary publication · 19349471 (PubMed) · PMC2682471 (PubMed Central)